Effect of autologous platelet rich plasma on grade ? knee meniscal tear

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300069077

Enrollment

Unknown

Registered

2023-03-06

Start date

2020-05-21

Completion date

Unknown

Last updated

2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

meniscal tear

Interventions

PRP injection Group:PRP injection

HA injection Group:Hyaluronic Acid injection

NS injection Control Group:Normal Saline injection

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1)Diagnosed as degenerative grade ? meniscal tear with knee MRI; (2) Physical examination with positive local tenderness of knee joint and positive McMurray test.

Exclusion criteria

Exclusion criteria: (1)Patients with meniscus injury who agree to surgical treatment; (2)Patients complicated with infectious diseases; (3)Patients complicated with blood diseases; (4)Patients complicated with moderate and severeknee osteoarthritis (Kellgren-Lawrence Grade 3 or 4).

Design outcomes

Primary

Measure	Time frame
KOOS score;Lysholm score;	—

Secondary

Measure	Time frame
Knee MRI;	—

Countries

China

Contacts

Public ContactGuoyou Zou

the First People’s Hospital of Yancheng

yczgy01@163.com15961972581

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026